Institution

IRCCS Ospedale San Raffaele

Milan, ItalyWebsite

Also known as: Istituto Scientifico Universitario San Raffaele · Ospedale San Raffaele

266running trials
95closed trials
53,655publications (OpenAlex)

Running trials

Not yet recruiting
Innovative 3D Preclinical Models for Mature B-cell Malignancies to Advance Personalized Immuno and Combination Therapies
NCT07759661· IRCCS San Raffaele· Source
Not yet recruiting
A Study Comparing Single-Port and Multi-Port Robot-Assisted Surgery in Patients With Prostate or Kidney (Renal) Cancer
NCT07610083· IRCCS San Raffaele· Source
Not yet recruiting
EUS-Based Artificial Intelligence to Predict Outcomes in Pancreatic Cancer
NCT07803770· IRCCS San Raffaele· Source
Recruiting
A clinical trial to assess the efficacy and safety of ontunisertib compared to placebo in patients with fibrostenosing Crohn’s disease
2026-525197-19-00· Phase 2· Agomab Spain S.L.U.· Source
Recruiting
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults with Symptomatic Genetic and Familial Dilated Cardiomyopathy (KINSHIP-OLE).
2026-526139-20-00· Phase 3· Kardigan Inc.· Source
Not yet recruiting
TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel Disease
NCT07740499· IRCCS San Raffaele· Source
Recruiting
A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
NCT07559175· Phase 2· Aimmune Nestlé Health Science US R&D, LLC· Source
Not yet recruiting
DYNAMIC ” IDentifY the best therapeutic sequeNcing strAtegy in oncogene addICted NSCLC:” “A multi-arms prospective, randomized phase II study to evaluate the best sequential therapeutic strategis in patients with metastatic non-small cell lung cancer harboring targetable genomic driver alterations”
2026-525268-16-00· Phase 2/3· Universita' Degli Studi Di Torino· Source
Recruiting
Evaluation of the DuoVT PFA System for Ventricular Tachycardia
NCT07706712· Abbott Medical Devices· Source
Not yet recruiting
Thymic Disease, Autoimmunity, and Neuromuscular Junction Integrity in Myasthenia Gravis
NCT07571525· IRCCS San Raffaele· Source
Recruiting
Single-arm Study of IgPro20 in Adults With Secondary Immune Deficiencies Due to Hematologic Malignancies Treated With B-cell Targeting Chimeric Antigen Receptor T-cell and T-cell Redirecting Therapies
NCT07648264· Phase 3· CSL Behring· Source
Not yet recruiting
Prospective Perioperative Clinical Registry for Women Undergoing Benign Gynecological Surgery
NCT07772076· IRCCS San Raffaele· Source
Not yet recruiting
Spectral and Ultra High Resolution CT Systems for Non-Invasive Detection of Myocardial Ischemia: Stress CT Perfusion VS. FFR-CT
NCT07544277· IRCCS San Raffaele· Source
Recruiting
A Phase 3 Study to Evaluate the Safety and Efficacy of AOC 1044 (Also Referred to as Delpacibart Zotadirsen) in Participants With DMD With Gene Mutations Amenable to Exon 44 Skipping
NCT07587242· Phase 3· Avidity Biosciences, Inc.· Source
Not yet recruiting
Italian Validation of the dNA Scale and Its Correlation With Neurocognitive Variables
NCT07533084· Neuromed IRCCS· Source
Not yet recruiting
ON-treatment Single-cell Analysis for the Identification of Early Tumor Response Biomarkers on Prospective Collected Serial Tumor Biopsies in Triple Negative Breast Cancer Patient During Standard Neoadjuvant Chemo-immunotherapy
NCT07597642· IRCCS San Raffaele· Source
Recruiting
A Study of the Long-term Safety and Efficacy of Danicamtiv in Adults With Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07771465· Phase 3· Kardigan, Inc.· Source
Recruiting
Gene-Modified Stem Cell Therapy for Subjects With Transfusion-dependent Beta-thalassemia
NCT07680803· Phase 2· Fondazione Telethon· Source
Recruiting
A Phase 3 Randomized Study Comparing JNJ-79635322 versus Teclistamab in Participants with Relapsed or Refractory Multiple Myeloma
2025-523815-12-00· Phase 3· Janssen Cilag International· Source
Active, not recruiting
The Aim of the Study is to Characterize Patients Exhibiting Muscular Atrophy and Weakness Who Require a Muscle Biopsy for Diagnosis (IBM vs Atypical MND), Through an Innovative Technique Which Enables the Evaluation of the Neuromuscular Junction Involvement in Each Condition
NCT07796776· IRCCS San Raffaele· Source
Not yet recruiting
M1no-Study - Early Identification of Infants With High Type 1 Diabetes Risk for Participation in Primary Prevention Trials
NCT07670143· IRCCS San Raffaele· Source
Not yet recruiting
AV Nodal Ablation With Conduction System Pacing Versus Cardiac Resynchronization for Symptomatic Heart Failure Patients With Atrial Fibrillation
NCT07604727· University Medical Center Groningen· Source
Recruiting
A Liquid Biopsy for Pancreatic Cancer Early-detection and Disease Monitoring
NCT07700992· Università Vita-Salute San Raffaele· Source
Not yet recruiting
A Study of Barrett's Esophagus Patients: Optimization of a Risk Model to Better Predict the Development of Cancer Recurrence and the Effect of Risk Profile Disclosure on Patient Quality of Life and Fear of Cancer
NCT07455422· University Hospital, Antwerp· Source
Recruiting
RO7771950 Versus Tucatinib in Combination With Trastuzumab and Capecitabine in People With Locally Advanced or Metastatic Breast Cancer That is Human Epidermal Growth Factor Receptor 2 (HER2)-Positive
NCT07413939· Phase 2/3· Hoffmann-La Roche· Source
Recruiting
Multicenter Study for External Validation of the TB-NET Score
NCT07903532· Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz· Source
Recruiting
Evaluating Adherence to Guideline-Directed Medical Therapy in Patients With Advanced Heart Failure
NCT07560982· Università Vita-Salute San Raffaele· Source
Recruiting
A Study of LY4395089 and Mirikizumab (LY3074828) Given Together and Mirikizumab (Alone) in Adults With Crohn's Disease
NCT07483099· Phase 2· Eli Lilly and Company· Source
Recruiting
ATLG Levels in Autologous HSCT for Multiple Sclerosis
NCT07635693· Ciceri Fabio· Source
Not yet recruiting
This Protocol Focuses on the Factors That Influence Survival, the Development of Complications and the Quality of Life Based on the Treatment Received in the Group of Patients Suffering From Malignant Lesions of the Head and Neck
NCT07066878· IRCCS San Raffaele· Source
Recruiting
Ultrasound Measurement of Thyroid Volume in Term Newborns
NCT07579988· IRCCS Ospedale San Raffaele· Source
Active, not recruiting
Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms
NCT07825207· Fondazione Italiana Sindromi Mielodisplastiche-ETS· Source
Recruiting
A Study of Guselkumab Versus Risankizumab in Participants With Moderately to Severely Active Crohn's Disease
NCT07499232· Phase 3· Janssen Research & Development, LLC· Source
Recruiting
A Study to See if Giving Fianlimab and Cemiplimab Together is Better Than Cemiplimab Alone at Treating Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
NCT06769698· Phase 2· Regeneron Pharmaceuticals· Source
Not yet recruiting
Anticipating Irreversible Disability in Neuromyelitis Optica Spectrum Disorder: a Study to Assess Disease Activity in Apparently Stable Patients
NCT07526298· IRCCS San Raffaele· Source
Recruiting
InRAD Observational Study
NCT07213700· Stichting International Registry for Alzheimer's Disease and other Dementias Foundation· Source
Recruiting
LY4268989 in Adults With Moderately to Severely Active Ulcerative Colitis
NCT07415044· Phase 2· Eli Lilly and Company· Source
Not yet recruiting
Spinal Cord Stimulation Combined With Motor Training in Non-Traumatic SCI: A Prospective Interventional Study
NCT07412808· Albano Luigi· Source
Not yet recruiting
Radiofrequency Ablation Multicenter Observational Study in Renal Oncology Patients
NCT07465458· Humanitas Hospital, Italy· Source
Not yet recruiting
Generation of Synthetic [18F]FDG PET From Early-Phase Amyloid PET in Alzheimer's Disease
NCT07431255· IRCCS San Raffaele· Source
Recruiting
A Study to Evaluate the Impact of Efgartigimod on Overall Disease Experience of People Suffering From Generalized Myasthenia Gravis (gMG) in Italy
NCT07595653· argenx· Source
Recruiting
A Study of the Efficacy and Safety of Danicamtiv in Participants with Symptomatic Genetic and Familial Dilated Cardiomyopathy.
2025-522553-19-00· Phase 2/3· Kardigan Inc.· Source
Recruiting
TACTIC Coronary Thrombus Aspiration With Cath Rx In Anterior Myocardial Infarction: A Randomized Control Trial.
NCT06887413· Ceric Sàrl· Source
Recruiting
A Study of the Efficacy and Safety of Danicamtiv in Participants With Symptomatic Genetic and Familial Dilated Cardiomyopathy
NCT07210723· Phase 2/3· Kardigan, Inc.· Source
Not yet recruiting
Hyperprogression upon cemiplimab alone or with chemotherapy in PD-L1 ≥ 50% NSCLC: a biomarker guided phase 2 trial – HYPERBOLIC study
2025-521583-35-00· Phase 2· Universita' Vita-salute S. Raffaele· Source
Recruiting
A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
NCT07063745· Phase 2/3· Bristol-Myers Squibb· Source
Enrolling by invitation
Autoimmune Hyperthyroidism in Prepubertal Children
NCT07544290· IRCCS Ospedale San Raffaele· Source
Not yet recruiting
Inherited Retinal Diseases: Natural History and Genotype-Phenotype Correlations
NCT07265895· IRCCS San Raffaele· Source
Recruiting
Achievement of LLDAS5 in Patients With Systemic Lupus Erythematosus Treated With Anifrolumab.
NCT07330245· AstraZeneca· Source
Recruiting
A Study to Evaluate the Safety and Efficacy of Pumitamig in Combination With Chemotherapy Versus Bevacizumab in Combination With Chemotherapy in Participants With Previously Untreated, Unresectable, or Metastatic Colorectal Cancer
NCT07221357· Phase 2/3· Bristol-Myers Squibb· Source

Showing 50 of 266.

Recruiting at the same time

How many trials recruit for the same indication here at once. A count, not a rating.

Lung cancer17 recruiting
Chronic lymphocytic leukaemia12 recruiting
Colorectal cancer11 recruiting
Gastric and oesophageal cancer10 recruiting
Heart failure10 recruiting
Pancreatic cancer10 recruiting
Crohn's disease9 recruiting
Bladder cancer8 recruiting
Kidney cancer8 recruiting
Liver and biliary tract cancer8 recruiting
Prostate cancer8 recruiting
Ulcerative colitis7 recruiting
Alzheimer disease6 recruiting
Diffuse large B-cell lymphoma6 recruiting
Follicular lymphoma6 recruiting
Childhood cancers5 recruiting
Coronary artery disease5 recruiting
ALS (motor neurone disease)4 recruiting
Dilated cardiomyopathy4 recruiting
Head and neck cancer4 recruiting
Mantle cell lymphoma4 recruiting
Metastatic breast cancer4 recruiting
Neuroendocrine tumours4 recruiting
Obesity4 recruiting
Ventricular tachycardia4 recruiting
Aortic stenosis3 recruiting
Multiple myeloma3 recruiting
Myasthenia gravis3 recruiting
Myeloproliferative neoplasms3 recruiting
Psoriasis3 recruiting
Acute myeloid leukaemia2 recruiting
Aortic aneurysm2 recruiting
Barrett's oesophagus2 recruiting
Cystic fibrosis2 recruiting
Duchenne muscular dystrophy2 recruiting
Endometrial cancer2 recruiting
Endometriosis2 recruiting
High blood pressure2 recruiting
HIV2 recruiting
Migraine2 recruiting
Multiple sclerosis2 recruiting
Myocarditis2 recruiting
Parkinson disease2 recruiting
Polycystic kidney disease2 recruiting
Psoriatic arthritis2 recruiting
Triple-negative breast cancer2 recruiting
Type 1 diabetes2 recruiting
Acute lymphoblastic leukaemia1 recruiting
Amyloidosis1 recruiting
ANCA-associated vasculitis1 recruiting
Atrial fibrillation1 recruiting
Chronic kidney disease1 recruiting
Dystonia1 recruiting
Frontotemporal dementia1 recruiting
Glioblastoma1 recruiting
Graves' disease and hyperthyroidism1 recruiting
Hepatitis B1 recruiting
Hepatitis C1 recruiting
Hodgkin lymphoma1 recruiting
Hypothyroidism1 recruiting
IgA nephropathy1 recruiting
Lupus (SLE)1 recruiting
Neuromyelitis optica (NMOSD)1 recruiting
Obstructive sleep apnoea1 recruiting
Osteoporosis1 recruiting
Ovarian cancer1 recruiting
Primary biliary cholangitis1 recruiting
Retinitis pigmentosa1 recruiting
Sarcoma1 recruiting
Spinal cord injury1 recruiting
Stroke1 recruiting
Thalassaemia1 recruiting
Thyroid cancer1 recruiting
Type 2 diabetes1 recruiting

Closed trials

Completed
Study on the Effect of the Intake of a Calcium-bicarbonate Water on Cholesterol Levels
NCT07026266· Società Generale delle Acque Minerali S.p.A.· Source
Completed
BURDEN OF ESOPHAGEAL CANCER IN EOSINOPHILIC ESOPHAGITIS (ESCAPE STUDY)
NCT07102329· IRCCS San Raffaele· Source
Recruiting
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
NCT06570798· Phase 2· Amgen· Source
Completed
Platelet Function and Impella Support
NCT06487091· Università Vita-Salute San Raffaele· Source
Completed
The Impact of Attentive System on Sleep Reactivity
NCT06694818· IRCCS San Raffaele· Source
Completed
LOW-PV Continuation
NCT06752941· FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS· Source
Completed
Semi-automatic Measurement of Renal Volume at CT Angiography to Plan Repair of Aortic Aneurysms in Patients With Horseshoe Kidney.
NCT06749782· IRCCS San Raffaele· Source
Completed
FOCALFLEX (CE Mark) Study
NCT06271967· Abbott Medical Devices· Source
Completed
Single arm phase II study of ctDNA-guided encorafenib plus cetuximab retreatment in patients with BRAF V600E mutated mCRC. BRICKET study
2023-509088-26-00· Phase 2· Fondazione GONO G.I.· Source
Completed
Evaluating efficacy and safety of switching a boosted protease inhibitor to fostemsavir in PLWH with limited therapeutic options (FOST Switch)
2023-504192-25-00· Phase 4· NEAT ID Foundation· Source
Completed
A Real-world Study in Participants With Smoldering Multiple Myeloma
NCT06472778· Janssen-Cilag Ltd.· Source
Recruiting
Combined Dose-Finding and CV Outcomes Study With CSL300 (Clazakizumab) in Adult Subjects With ESKD Undergoing Dialysis (POSIBIL6ESKD)
NCT05485961· Phase 2/3· CSL Behring· Source
Recruiting
A Study to Evaluate TAR-210 Versus Single Agent Intravesical Cancer Treatment in Participants With Bladder Cancer
NCT06319820· Phase 3· Janssen Research & Development, LLC· Source
Completed
Study to Assess Safety and Efficacy of PRI-002 in Patients With MCI to Mild Dementia Due to Alzheimer's Disease (AD)
NCT06182085· Phase 2· PRInnovation GmbH· Source
Active, not recruiting
A Study to Learn About the Study Medicine Called PF-07220060 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment
NCT06105632· Phase 2· Pfizer· Source
Completed
Overtaking Intra and Inter Tumoral Heterogeneity In Von Hippel-Lindau Related Renal Cancer
NCT06195150· IRCCS San Raffaele· Source
Completed
A Study to Investigate the Family History of Cancer in Patients With Non-small Cell Lung Cancer (FAHIC - Lung).
NCT06196424· Fondazione Policlinico Universitario Campus Bio-Medico· Source
Completed
The Isthmus Logic Post Market Clinical Follow-up Study
NCT05616143· CID S.p.A.· Source
Completed
Phase 2/3 Study of Navtemadlin as Maintenance Therapy in TP53WT Advanced or Recurrent Endometrial Cancer
2022-502196-31-00· Phase 2/3· Kartos Therapeutics Inc.· Source
Completed
STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease
NCT05843578· Phase 2· Agomab Spain S.L.U.· Source
Completed
A Study of Tobemstomig + Nab-Paclitaxel Compared With Pembrolizumab + Nab-Paclitaxel in Participants With Previously Untreated, PD-L1-Positive, Locally-Advanced Unresectable or Metastatic Triple-Negative Breast Cancer
NCT05852691· Phase 2· Hoffmann-La Roche· Source
Completed
AnGiographic Performance With A Sirolimus-elutiNG Balloon in the TrEatment of De Novo CoronaRy Artery Disease
NCT05471245· Fondazione Evidence per Attività e Ricerche Cardiovascolari ONLUS· Source
Completed
A Study in Participants With Major Depressive Disorder (MDD) With Anhedonia and Inadequate Response to Current Antidepressant Therapy Including a Selective Serotonin Reuptake Inhibitor (SSRI) or Serotonin Norepinephrine Reuptake Inhibitor (SNRI)
NCT05841030· Janssen Research & Development, LLC· Source
Terminated
Study to Evaluate the Clinical Activity and Safety of Oral NX-13 in Moderate to Severe Ulcerative Colitis
NCT05785715· Phase 2· AbbVie· Source
Completed
Spinal Cord Stimulation Assisted by Motor Rehabilitation Training for Restoring Motor Function After Spinal Cord Injury
NCT05926843· IRCCS San Raffaele· Source
Withdrawn
Phase 2 Study of Neoadjuvant PEMbrolizumab Before Radical PROstatectomy in High-risk Prostate Cancer Patients
NCT04565496· Phase 2· IRCCS San Raffaele· Source
Completed
A Study of Vedolizumab in Adults With Crohn's Disease (CD)
NCT05192863· Takeda· Source
Completed
Artificial Intelligence & Prostate Cancer
NCT06298305· IRCCS San Raffaele· Source
Completed
Immune Activation, Neural Plasticity and Depression
NCT06306248· IRCCS San Raffaele· Source
Terminated
A Study of TCD601 (Siplizumab) in New Onset Type 1 Diabetes Patients
NCT06025110· Phase 2· ITB-Med LLC· Source
Completed
Extension Study Evaluating The Safety And Tolerability of AMX0035
NCT05619783· Phase 3· Amylyx Pharmaceuticals Inc.· Source
Completed
An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis
NCT05616871· AbbVie· Source
Completed
Passive Music Listening in Acute Cerebrovascular Disease
NCT06743412· IRCCS Ospedale San Raffaele· Source
Completed
A Study of Aticaprant as Adjunctive Therapy in Adult Participants With Major Depressive Disorder (MDD) With Moderate-to-severe Anhedonia and Inadequate Response to Current Antidepressant Therapy
NCT05455684· Phase 3· Janssen Research & Development, LLC· Source
Terminated
A Study to Verify the Clinical Benefit of Aducanumab in Participants With Early Alzheimer's Disease
NCT05310071· Phase 3· Biogen· Source
Terminated
Study to Evaluate the Efficacy and Safety of Pemigatinib in Participants With Previously Treated Glioblastoma or Other Primary Central Nervous System Tumors Harboring Activating FGFR1-3 Alterations
NCT05267106· Phase 2· Incyte Corporation· Source
Completed
Development and Validation of a Comorbidity Index in Crohn's Disease
NCT05253378· Central Hospital, Nancy, France· Source
Terminated
Study of Posoleucel (ALVR105,Viralym-M) for Multi-Virus Prevention in Patients Post-Allogeneic Hematopoietic Cell Transplant
NCT05305040· Phase 2/3· AlloVir· Source
Terminated
An Umbrella Study to Determine the Safety and Efficacy of Various Monotherapy or Combination Therapies in Neoadjuvant Urothelial Carcinoma
NCT04586244· Phase 2· Incyte Corporation· Source
Completed
Ischemia in Patients With Non-obstructive Disease (INOCA) in Italy INOCA IT Multicenter Registry"
NCT05164640· IRCCS San Raffaele· Source
Terminated
The Efficacy and Safety of Cobitolimod in Participants With Moderate to Severe Active Left-Sided Ulcerative Colitis
NCT04985968· Phase 3· InDex Pharmaceuticals· Source
Completed
A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis
NCT05081557· AbbVie· Source
Completed
A Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic Arthritis
NCT05071664· Phase 2· Janssen Research & Development, LLC· Source
Completed
A Study of Nipocalimab in Adults With Primary Sjogren's Syndrome (pSS)
NCT04968912· Phase 2· Janssen Research & Development, LLC· Source
Recruiting
Association of Plasma N-terminal Pro-Brain Natriuretic Peptide Levels With the Burden of Coronary Artery Disease
NCT07013344· IRCCS Ospedale San Raffaele· Source
Completed
AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study
NCT05028660· Elypta· Source
Terminated
To Evaluate the Efficacy and Safety of Parsaclisib and Ruxolitinib in Participants With Myelofibrosis (LIMBER-313)
NCT04551066· Phase 3· Incyte Corporation· Source
Completed
Imaging Guided Surgery to Improve the Detection of Lymph Node Metastases in Prostate Cancer Patients
NCT04832958· Phase 2· IRCCS San Raffaele· Source
Completed
Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
NCT04607837· Phase 2· Pfizer· Source
Completed
MELD-ATG: Phase II, Dose Ranging, Efficacy Study of Anti-thymocyte Globulin (ATG) Within 6 Weeks of Diagnosis of Type 1 Diabetes (T1D)
NCT04509791· Phase 2· Universitaire Ziekenhuizen KU Leuven· Source

Showing 50 of 95.

Registry name variants (121)

Trial registries list this institution under these names. Each row is one registry entry: its address and the trials registered under it.

IRCCS Ospedale San Raffaele
Milan, 20132
132 trials
Ospedale San Raffaele
Milan, Lombardy 20132
84 trials
San Raffaele Hospital
Milan, 20132
46 trials
IRCCS San Raffaele Hospital
Milan, MI 20132
16 trials
IRCCS - Ospedale San Raffaele
Milano, 20132
7 trials
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele
Milan, Milan 20132
7 trials
Ospedale San Raffaele - Milano
Milan, 20132
3 trials
- NCT06585774A Study to Evaluate Axatilimab and Corticosteroids as Initial Treatment for Chronic Graft-Versus-Host Disease
- NCT05149755Evolut™ EXPAND TAVR II Pivotal Trial
- NCT02088554PERIGON Pivotal Trial
Ospedale San Raffaele, Unità Operativa di Ematologia e Trapianto Midollo Osseo
Milan
3 trials
- NCT06752941LOW-PV Continuation
- NCT06533813Clinical Epidemiology in Contemporary Patients With Myelofibrosis.
  Contact: Antonella Danese
- NCT06506084Observational Study on the Use of Ropeginterferon Alfa-2b in Polycythemia Vera (ROPEG-PV)
  Contact: Antonella Danese
Gastronterology and Gastrointestinal Endoscopy Unit, IRCCS San Raffaele Hospital
Milan, Lombardy 20132
2 trials
- NCT07450612Liquid Biopsy and Machine Learning for Early Colorectal Cancer, Adenomas, Lynch Cancers, and Residual Disease Detection
  Contact: Giulia Martina Cavestro, MD, PhD
- NCT06708429Lynch Syndrome X-Talk of Enteral Mucosa With Immune System
  Contact: Giulia Martina Cavestro, MD, PhD
Hospital San Raffaele
Milan, Italy 20132
2 trials
- NCT07026266Study on the Effect of the Intake of a Calcium-bicarbonate Water on Cholesterol Levels
- NCT05843578STENOVA - A Study to Evaluate Safety, Tolerability, PK and PD of AGMB-129 in Patients With Fibrostenotic Crohn's Disease
Ospedale San Raffaele - Cardiac
Milan
2 trials
- NCT06008080Post-Market Clinical Follow Up Study With Navitor Valve
  Contact: Francesco Maisano
- NCT04788888Evaluation of TAVR Using the NAVITOR Valve in a Global Investigation
Ospedale San Raffaele, IRCCS
Milan, 20132
2 trials
- NCT06747585A Study to Investigate ALE.P02 as a Monotherapy or in Combination With Pembrolizumab in Adult Patients With Selected CLDN1+ Solid Tumors
- NCT03465982Timing to Minimally Invasive Surgery After Neoadjuvant Chemoradiotherapy for Rectal Cancer
  Contact: Ugo Elmore
Ospedale San Raffaele, IRCCS - Oncologia Medica
Milan, 20132
2 trials
- NCT07169734A Study to Investigate ALE.P03 as Monotherapy in Adult Patients With Selected Advanced or Metastatic CLDN1+ Solid Tumors
  Contact: Principal Investigator
- NCT06054555A Study to Evaluate ABP 206 Compared With OPDIVO® (Nivolumab) in Subjects With Unresectable or Metastatic Melanoma
Deaprtment of Radiology, IRCCS Ospedale San Raffaele
Milan, 20132
1 trial
- NCT04359732Assessment of Response to nCRT for GEJ Cancer Using a Fully Integrated PET/MRI
Department of Radiology, IRCCS Ospedale San Raffaele
Milan, 20132
1 trial
- NCT05714111Radiology Registry on Pancreatic Malignancies
  Contact: Francesco De Cobeli, MD
DIMER, IRCCS, Ospedale San Raffaele
Milan
1 trial
- NCT06414954Safety and Efficacy of 3 Dose Levels of NMD670 in Adult Patients With Myasthenia Gravis
  Contact: Dr.ssa Claudia Panciroli
Dipartimento di Oncologia Medica, IRCCS Ospedale San Raffaele
Milan, 20132
1 trial
- NCT01889238Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer
Dipartimento di Radiologia, Ospedale San Raffaele
Milan, 20132
1 trial
- NCT02003924Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
Endocrinologia Infantile, UOU di Pediatria, IRCCS Ospedale San Raffaele
Milan
1 trial
- NCT06645951Institution of an Italian Multicenter Database of Patients with Parathyroid Carcinoma or Atypical Parathyroid Adenoma
  Contact: Stefano Mora, MD
Farmacia (magazzino ricevimento merc), IRCCS Ospedale San Raffaele
Milan, 20132
1 trial
- NCT01889238Safety and Efficacy Study of Enzalutamide in Patients With Advanced, Androgen Receptor-Positive, Triple Negative Breast Cancer
Ginecologia e Ostetricia, IRCCS Ospedale San Raffaele
Milan
1 trial
- NCT05733806Study on Gynecological Rare Cancers
  Contact: Giorgia Mangili, MD
Hospital San Raffaele, IRCCS, Unit of Immunology, Rheumatology, Allergy and Rare Diseases
Milan, 20132
1 trial
- NCT06782373A Study to Assess the Effectiveness and Safety of Pacritinib in Patients With VEXAS Syndrome (PAXIS)
  Contact: Study Physician
IRCCS Ospedale San Raffaele
Segrate, 20132
1 trial
- NCT06598943A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative Colitis
Irccs Ospedale San Raffaele - Area Unica Di Terapia Intensiva Cardiologica E Cch
Milan, MILANO 20132
1 trial
- NCT07283809European Unified Registries for Heart Care Evaluation and Randomised Trials Italy
  Contact: Vittorio Pazzanese, MD
IRCCS Ospedale San Raffaele, Chirurgia Vascolare
Milan, 20132
1 trial
- NCT04503395ShOrt neCK AAA RAndomized Trial - ESAR and FEVAR: SOCRATES
  Contact: Andrea Kahlberg, Prof
IRCCS Ospedale San Raffaele - Cognitive Disorders and Dementia Center (CDCD)
Milan, Milano 20132
1 trial
- NCT07717567Blood Tests for Alzheimer's Disease: Can Plasma Biomarkers Diagnose and Predict Disease Progression
  Contact: Federica Agosta, MD
IRCCS Ospedale San Raffaele - Endoscopia Biliopancreatica
Milan, 20132
1 trial
- NCT07559175A Study to Evaluate Safety and Explore Efficacy of New Lipase NHS7108 in Adult Participants With Exocrine Pancreatic Insufficiency.
  Contact: Gabriele Capurso
IRCCS Ospedale San Raffaele /ID# 251562
Milan, Milano 20132
1 trial
- NCT05616871An Observational Study to Assess Change in Disease Activity and Treatment Patterns of Upadacitinib When Given Alone or Co-Administered With Methotrexate in Adult Participants With Active Psoriatic Arthritis
IRCCS Ospedale San Raffaele /ID# 253531
Milan, Milano 20132
1 trial
- NCT05753501Study to Evaluate Adverse Events, Change in Disease Activity, and How Oral ABBV-101 Moves Through the Body in Adult Participants With B-Cell Malignancies
IRCCS Ospedale San Raffaele /ID# 255285
Milan, Milano 20132
1 trial
- NCT05081557A Study to Assess Real-World Use, Safety, and Effectiveness of Oral Upadacitinib in Adult and Adolescent (>=12 Years Old) Participants With Atopic Dermatitis
IRCCS Ospedale San Raffaele /ID# 261058
Milan, Milano 20132
1 trial
- NCT05494606An Observational Study to Assess Change in Disease Activity and Adverse Events of Upadacitinib in Adult Participants With Moderate to Severe Ulcerative Colitis (UC) in Real-World Practice
IRCCS Ospedale San Raffaele /ID# 265127
Milan, Milano 20132
1 trial
- NCT05841537An Observational Study to Assess Change in Disease Activity and Adverse Events In Adult Participants With Moderate to Severe Active Crohn's Disease (CD)
IRCCS Ospedale San Raffaele /ID# 266212
Milan, Milano 20132
1 trial
- NCT06764693An Ex-US Study to Assess Treatment Persistence With Risankizumab in Adult Participants With Psoriatic Arthritis
  Contact: Shari Chapman
IRCCS Ospedale San Raffaele /ID# 268426
Milan, Milano 20132
1 trial
- NCT05930275Study to Assess Speed of Onset and Durability of Effectiveness of Upadacitinib in Adult Participants With Moderate to Severe Crohn's Disease (CD) in Real World Clinical Practice.
IRCCS Ospedale San Raffaele /ID# 273153
Milan, Milano 20132
1 trial
- NCT06543914Observational Study of Oral Atogepant to Evaluate Real-World Effectiveness in Adult Participants With Migraine
IRCCS Ospedale San Raffaele /ID# 274458
Milan, Milano 20132
1 trial
- NCT07073079A Study to Assess the Effectiveness of Second-Line Therapy of Upadacitinib and Risankizumab in Adult Participants With Crohn's Disease in a Real-World Setting
  Contact: Caterina Golotta
IRCCS Ospedale San Raffaele /ID# 274789
Milan, Milano 20132
1 trial
- NCT06830759Real-World Study to Assess Subcutaneous Epcoritamab in Adult Participants With Diffuse Large B-Cell and Follicular Lymphoma
  Contact: Rebekah Taylor
IRCCS Ospedale San Raffaele /ID# 277342
Milan, Milano 20132
1 trial
- NCT07039110Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
  Contact: Julieta Gonzalez Blanco
IRCCS Ospedale San Raffaele - Neurology and Neurophysiology Unit
Milan, Milano 20132
1 trial
- NCT07720765Optical Coherence Tomography in Neurological Practice: Utility and Applicability Across Neurological Diseases (OCt.IN.N)
  Contact: Federica Agosta, MD
IRCCS Ospedale San Raffaele, San Raffaele Hospital
Milan
1 trial
- NCT05028660AURORAX-0093A: Glycosaminoglycan Profiling for Prognostication of Muscle-invasive Bladder Cancer - a Pilot Study
IRCCS Ospedale San Raffaele (Site 0171)
Milan, 20132
1 trial
- NCT04165798KEYMAKER-U01 Umbrella Master Study: Studies of Investigational Agents With Either Pembrolizumab (MK-3475) Alone or With Pembrolizumab PLUS Chemotherapy in Participants With Non-small Cell Lung Cancer (NSCLC) (MK-3475-U01/KEYMAKER-U01)
  Contact: Toll Free Number
IRCCS Ospedale San Raffaele (Site 1402)
Milan, 20132
1 trial
- NCT04728893Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)
  Contact: Study Coordinator
IRCCS Ospedale San Raffaele (Site 1409)
Milan, 20132
1 trial
- NCT04586231A Study of Belzutifan (MK-6482) in Combination With Lenvatinib Versus Cabozantinib for Treatment of Renal Cell Carcinoma (MK-6482-011)
IRCCS Ospedale San Raffaele (Site 4600)
Milan, 20132
1 trial
- NCT06841354A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
  Contact: Study Coordinator
IRCCS Ospedale San Raffaele SRL
Milan
1 trial
- NCT07268833Translating Single-cell Vulnerability Into Novel ALS Biomarkers and Therapeutic Targets: Towards a Liquid Nerve Biopsy
  Contact: Angelo Quattrini, MD
IRCCS Ospedale San Raffaele, Unita di Gastroenterologia
Milan, Milan 20132
1 trial
- NCT04607837Etrasimod Versus Placebo for the Treatment of Moderately Active Ulcerative Colitis
IRCCS Ospedale San Raffaele - Università Vita-Salute San Raffaele di Milano
Milan, 20132
1 trial
- NCT05131022A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
IRCCS Ospedale San Raffaele - U.O. Ginecologia e Ostetricia
Milan, Milano
1 trial
- NCT07772076Prospective Perioperative Clinical Registry for Women Undergoing Benign Gynecological Surgery
  Contact: Massimo Candiani, MD, Professor
IRCCS Ospedale San Raffaele ,Via Olgettina 60
Milan, Italia 20132
1 trial
- NCT05817942Prospective Observational Study of Effectiveness and Safety of Filgotinib in Participants With Ulcerative Colitis (UC)
IRCCS San Raffaele Hospital, Milano
Milan, Lombardy 20132
1 trial
- NCT06516237Development of Novel Imaging and Molecular Biomarkers of Fibrosis in Patient With Ulcerative Colitis
  Contact: MARIANGELA ALLOCCA, MD, PhD
IRCCS San Raffaele Hospital - Sleep Disorders Center
Milan, Italy 20127
1 trial
- NCT06677580Multidisciplinary Network OSA Code (Obstructive Apnea Syndrome): Digital Operative Model in Public Health for an Early Diagnosis and Therapy Monitoring
  Contact: Luigi Ferini Strambi, MD
Istituto Di Ricovero E Cura A Carattere Scientifico (Irccs) - Ospedale San Raffaele (Hsr) (Istituto
Milan, 20132
1 trial
- NCT06821542A Study to Evaluate Axatilimab Versus Best Available Therapy in Participants With Chronic Graft Versus Host Disease After at Least 2 Prior Lines of Systemic Therapy
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario San Raffaele)
Milan, 20132
1 trial
- NCT07207811CLEOPATTRA: A Research Study to Look at the Effects of Treatment With a Medicine Called Coramitug (NNC6019-0001) in People With Heart Failure Due to Transthyretin Amyloid (ATTR) Amyloidosis
  Contact: Novo Nordisk
Istituto Scientifico Universitario San Raffaele
Milan, 20132
1 trial
- NCT03596866A Study of Brigatinib Compared to Alectinib in Adults With Non-Small-Cell Lung Cancer
Ospedale San Raffaele
Segrate
1 trial
- NCT02947685Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer
Ospedale San Raffaele - Aritmologia
Milan, Lombard 20132
1 trial
- NCT02879448AMPLATZER™ Amulet™ LAA Occluder Trial
Ospedale San Raffaele - Chirurgia Gastroenterologica
Milan, MI 20132
1 trial
- NCT06466902Evaluation of Intra-operative Photographs for the Assessment of a Proper Lymphadenectomy in Minimally-invasive Gastrectomies for Gastric Cancer (PhotoNodes)
  Contact: Federico Marchesi, Prof
Ospedale San Raffaele IRCCS /ID# 1142-0523
Milan, Lombardy 20132
1 trial
- NCT02910583Ibrutinib Plus Venetoclax in Subjects With Treatment-naive Chronic Lymphocytic Leukemia /Small Lymphocytic Lymphoma (CLL/SLL)
Ospedale San Raffaele IRCCS /ID# 125261
Milan, Lombardy 20132
1 trial
- NCT02163694A Phase 3 Randomized, Placebo-controlled Trial of Carboplatin and Paclitaxel With or Without Veliparib (ABT-888) in HER2-negative Metastatic or Locally Advanced Unresectable BRCA-associated Breast Cancer
Ospedale San Raffaele IRCCS /ID# 229059
Milan, Milano 20132
1 trial
- NCT04497597A Study of Oral Upadacitinib Tablets to Assess Treatment Patterns, Achievement of Treatment Targets and Maintenance of Response in Adult Participants With Moderate to Severe Rheumatoid Arthritis
Ospedale San Raffaele. (Site 1502)
Milan, 20132
1 trial
- NCT07060807A Clinical Study of Patritumab Deruxtecan to Treat Breast Cancer (MK-1022-016)
  Contact: Study Coordinator
Ospedale San Raffaele - U.O. di Oncologia Medica
Milan
1 trial
- NCT05327530A Study of the Safety and Efficacy of Various Combinations of Avelumab as Therapy in Locally Advanced or Metastatic Urothelial Carcinoma (JAVELIN Bladder Medley)
Pediatric Immunohematology Unit, IRCCS Ospedale San Raffaele
Milan, 20132
1 trial
- NCT07740499TOLerogenic Potential of Hematopoietic Stem and Progenitor Cells and Inflammatory Bowel Disease
  Contact: Federica Barzaghi, MD
Radiation oncology unit, Ospedale San Raffaele
Milan, Milano 20132
1 trial
- NCT07401615Stereotactic Body Radiotherapy (SBRT) for Reirradiation of Inoperable Lung Lesions
  Contact: Roberta Tumminieri, MD, radiation oncologist
San Raffaele Hospital, Arrhythmology and Electrophysiology unit
Milan, Italy 20132
1 trial
- NCT06669299Non-Invasive Programmed Stimulation (NIPS) to Guide the Subsequent VT Therapeutic Strategies
  Contact: Paolo Della Bella, MD
San Raffaele Hospital IRCCS
Milan, 20132
1 trial
- NCT03012789Surgical Intervention and the NETest
San Raffaele Hospital (Ospedale San Raffaele)
Milan
1 trial
- NCT03127267Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
  Contact: Clinical Study Coordinator
San Raffaele Hospital - Sleep Disorders Center, Department of Neurology, Turro
Milan, Milano 20127
1 trial
- NCT07729748Predicting Parkinson's Disease Before It Strikes: A Brain Imaging Study in At-Risk Individual
San Raffaele Scientific Institute, Milan, Italy; Division of Experimental Oncology/Unit of Urology, URI, IRCCS San Raffaele Hospital
Milan, 20132
1 trial
- NCT05363657International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
  Contact: Umberto Capitanio
Servizio di Farmacia, Ospedale San Raffaele
Milan, 20132
1 trial
- NCT02003924Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
Unità di Ematologia e TMO, IRCCS Ospedale San Raffaele
Milan
1 trial
- NCT07825207Observational Study on Eltrombopag in Hypocellular Myelodysplastic Neoplasms
Unità di Ematologia e TMO - Unità Linfomi, Ospedale San Raffaele
Milan
1 trial
- NCT05977673Efficacy and Safety of Frontline Tislelizumab in Patients With de Novo Hodgkin Lymphoma Unsuitable for Standard Frontline Chemotherapy
  Contact: Andrés J.M. Ferreri, MD
U.O. di Medicina Nucleare e Centro PET, Ospedale San Raffaele
Milan, 20132
1 trial
- NCT02003924Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
U.O. di Urologia, Ospedale San Raffaele
Milan, 20132
1 trial
- NCT02003924Safety and Efficacy Study of Enzalutamide in Patients With Nonmetastatic Castration-Resistant Prostate Cancer
UO epatologia, Istituto scientifico universitario San Raffaele
Milan
1 trial
- NCT05151809National Database on Primary Biliary Cholangitis
  Contact: Pietro Invernizzi, MD
U.O. of Nuclear Medicine, ,Ospedale San Raffaele
Milan, Milano 20132
1 trial
- NCT06305390Fully Hybrid 18F-PSMA PET/MRI as One-stop Approach for the Diagnosis of Clinically Significant Prostate Cancer.
  Contact: Maria Picchio, MD
Duplicate_Ospedale San Raffaele IRCCS /ID# 241167
Milan, Milano 20132
IRCCS Ospedale San Raffaele
Candiolo, 10060
Irccs Ospedale San Raffaele, Gastroenterologia/Ibd Unit, Settore G Piano -1
Milan, 20132
IRCCS Ospedale San Raffaele (HSR) - Dipartimento Di Neurologia
Milan, 20132
IRCCS Ospedale San Raffaele /ID# 225555
Milan, Milano 20132
IRCCS Ospedale San Raffaele /ID# 226973
Milan, Milano 20132
IRCCS Ospedale San Raffaele /ID# 228669
Milan, Milano 20132
IRCCS Ospedale San Raffaele /ID# 242583
Milan, Milano 20132
IRCCS Ospedale San Raffaele /ID# 252910
Milan, Milano 20132
IRCCS Ospedale San Raffaele /ID# 254376
Milan, Milano 20132
IRCCS Ospedale San Raffaele /ID# 256404
Milan, Milano 20132
IRCCS Ospedale San Raffaele /ID# 258592
Milan, Milano 20132
IRCCS Ospedale San Raffaele /ID# 263035
Milan, Milano 20132
IRCCS Ospedale San Raffaele /ID# 263064
Milan, Milano 20132
IRCCS Ospedale San Raffaele /ID# 265951
Milan, Milano 20132
IRCCS Ospedale San Raffaele /ID# 269475
Milan, Milano 20132
IRCCS Ospedale San Raffaele /ID# 274516
Milan, Milano 20132
IRCCS Ospedale San Raffaele /ID# 276793
Milan, Milano 20132
IRCCS Ospedale San Raffaele, Oculistica
Milan, Lombardy 20132
IRCCS Ospedale San Raffaele (Site 0362)
Milan, 20132
IRCCS Ospedale San Raffaele (Site 0539)
Milan, 20132
IRCCS Ospedale San Raffaele (Site 0596)
Milan, 20132
IRCCS Ospedale San Raffaele (Site 1500)
Milan, 20132
IRCCS Ospedale San Raffaele (Site 2012)
Milan, 20132
IRCCS Ospedale San Raffaele (Site 2130)
Milan, 20132
IRCCS Ospedale San Raffaele-Site Number : 3800001
Milan, Milano 20132
IRCCS Ospedale San Raffaele-Site Number : 3800006
Milan, Milano 20132
IRCCS Ospedale San Raffaele, U.O. Farmacia Studi Clinici
Milan, 20132
IRCCS Ospedale San Raffaele, URI (Urological Research Institute)
Milan, 20132
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele Hospital
Milan, 20132
Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) - Ospedale San Raffaele (HSR) (Istituto Scientifico Universitario Sa
Milan, 20132
Ospedale San Raffaele
Rozzano, Milano 20089
Ospedale San Raffaele - 2307
Milan, 20132
Ospedale San Raffaele (HSR) Instituto Scientifico Universitario San Raffaele
Milan, 20132
Ospedale San Raffaele (HSR) - Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS)
Milan, Milano 20132
Ospedale San Raffaele, Merz Investigational Site #0390027
Milan, 20132
Ospedale San Raffaele (San Raffaele Turro)
Milan, 20127
Ospedale San Raffaele. (Site 0171)
Milan, 20132
Ospedale San Raffaele. (Site 0194)
Milan, 20132
Ospedale San Raffaele (Site #0907)
Milan, 20132
Ospedale San Raffaele. (Site 1104)
Milan, 20132
Ospedale San Raffaele. (Site 1305)
Milan, 20132
Ospedale San Raffaele. (Site 2106)
Milan, 20132
Ospedale San Raffale, IRCCS
Milan, 20132
Unità di Oculistica, IRCCS Ospedale San Raffaele
Milan, Milano 20132

Conditions

Diseases this institution publishes on or runs trials for.

Heart failure149 works · 15 trials
Bladder cancer139 works · 15 trials
Prostate cancer136 works · 14 trials
Multiple sclerosis120 works · 5 trials
Ulcerative colitis108 works · 14 trials
Crohn's disease97 works · 15 trials
Liver and biliary tract cancer86 works · 9 trials
Systemic sclerosis (scleroderma)81 works · 0 trials
HIV79 works · 3 trials
Kidney cancer76 works · 11 trials
Pancreatic cancer58 works · 14 trials
Type 1 diabetes47 works · 4 trials
Chronic kidney disease47 works · 3 trials
Depression35 works · 4 trials
Bipolar disorder31 works · 0 trials
Chronic lymphocytic leukaemia30 works · 17 trials
Acute myeloid leukaemia27 works · 4 trials
Macular degeneration25 works · 2 trials
Myocarditis24 works · 2 trials
Neuroendocrine tumours23 works · 6 trials
Aortic stenosis23 works · 9 trials
Lupus (SLE)22 works · 4 trials
Migraine20 works · 3 trials
Diabetic eye disease18 works · 2 trials
Insomnia18 works · 1 trial
ALS (motor neurone disease)16 works · 6 trials
Metastatic breast cancer14 works · 15 trials
Acute lymphoblastic leukaemia13 works · 1 trial
Endometriosis13 works · 2 trials
Pulmonary arterial hypertension13 works · 1 trial

Institution data: ROR 039zxt351 (CC0-1.0)Updated 12 Nov 2026

Report an error